19.02.2018 20:37:00
|
Lifshitz & Miller LLP Announces Investigation of A10 Networks, Inc., Aerohive Networks, Inc., Jacksonville Bancorp, Inc., Key Technology, Inc., MabVax Therapeutics Holdings, Inc., MetLife Inc.
NEW YORK, Feb. 19, 2018 /PRNewswire/ --
A10 Networks, Inc. (ATEN)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the Company's revenue recognition practices from the fourth quarter of 2015 through the first quarter of 2017.
If you are an A10 Networks investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Aerohive Networks, Inc. (HIVE)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with underlying sales execution issues uncovered at the end of the third quarter of 2017 resulting in overstatement of Aerohive's revenue guidance.
If you are an Aerohive investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Jacksonville Bancorp, Inc. (JXSB)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with Jacksonville Bancorp's proposed sale to CNB Bank Shares, Inc., for $33.70 per share.
If you are a Jacksonville Bancorp investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Key Technology, Inc. (KTEC)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with Key's proposed sale to Duravant LLC for $26.75 per share.
If you are a Key investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
MabVax Therapeutics Holdings, Inc. (MBVX)
Lifshitz & Miller announces its investigation into possible securities law violations in addition to SEC investigation concerning MabVax's filed registration statements and subsequent amendments.
If you are a MabVax investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
MetLife Inc. (MET)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with MetLife's January 29, 2018 disclosure of "material weakness in internal controls over financial reporting," as well as revealing the existence of an ongoing investigation by the SEC surrounding outstanding pension payments.
If you are a MetLife investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Xerox Corporation (XRX)
Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with an agreement with Fujifilm Holdings Corporation ("Fujifilm") to combine their longstanding Fuji Zerox joint venture, whereby shareholders of Xerox will receive approximately $9.80 per share and own 49.9% of the combined company.
If you are a Xerox investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2018 Lifshitz & Miller LLP. The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
SOURCE Lifshitz & Miller Law Firm
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu MetLife Inc.mehr Nachrichten
21.11.24 |
S&P 500-Wert MetLife-Aktie: So viel Gewinn hätte ein Investment in MetLife von vor 3 Jahren eingefahren (finanzen.at) | |
14.11.24 |
S&P 500-Titel MetLife-Aktie: So viel Gewinn hätte ein Investment in MetLife von vor einem Jahr abgeworfen (finanzen.at) | |
07.11.24 |
S&P 500-Papier MetLife-Aktie: So viel Gewinn hätte eine MetLife-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
31.10.24 |
S&P 500-Wert MetLife-Aktie: So viel Gewinn hätte eine MetLife-Investition von vor 5 Jahren eingebracht (finanzen.at) | |
29.10.24 |
Ausblick: MetLife mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
24.10.24 |
S&P 500-Titel MetLife-Aktie: So viel hätten Anleger mit einem Investment in MetLife von vor 3 Jahren verdient (finanzen.at) | |
17.10.24 |
S&P 500-Titel MetLife-Aktie: So viel hätten Anleger an einem MetLife-Investment von vor einem Jahr verdient (finanzen.at) | |
15.10.24 |
Erste Schätzungen: MetLife vermeldet Zahlen zum jüngsten Quartal (finanzen.net) |